Trials / Sponsors / Pardes Biosciences, Inc.
Pardes Biosciences, Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19 COVID-19 | Phase 2 | 2022-09-21 |
| Completed | Study of PBI-0451 in Healthy Subjects. Covid19 | Phase 1 | 2021-08-14 |